CCL

Összesen 3 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM112811
035-os BibID:(cikkazonosító)321 (WoS)001016138200002 (Scopus)85163149718
Első szerző:Takács Péter (szülész-nőgyógyász)
Cím:A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence / Takacs Peter, Pákozdy Krisztina, Koroknai Erzsébet, Erdődi Balázs, Krasznai Zoárd, Kozma Bence
Dátum:2023
ISSN:1472-6874
Megjegyzések:Background: Pelvic floor muscle training (PFMT) is the first-line treatment approach for stress urinary incontinence. Creatine and leucine have been shown to improve muscle function. Our aim was to assess the effectiveness of a food supplement and PFMT in women with stress-predominant urinary incontinence. Methods: Women with stress-predominant urinary incontinence were randomized in 1:1 ratio to receive daily oral supplementation for six weeks with either a food supplement (treatment group) or placebo (control group). Both groups were instructed to perform standardized daily PFMT. The primary outcome was the Urogenital Distress Inventory Short Form (UDI-6) score. Secondary outcomes were the Incontinence Impact Questionnaire (IIQ?7) score, Patient's Global Impression of Severity (PGI?S), and Biomechanical Integrity score (BI-score) measured by Vaginal Tactile Imager. To have a power of 80% and a significance level of 5% to detect a decrease of 16 points in the UDI-6 score, a sample size of 32 was needed, with 16 patients in each arm of our trial. Results: Sixteen women in the control group and sixteen in the treatment group completed the trial. Between-group analysis revealed no significant differences between the control and treatment group except for mean change (delta) in vaginal squeeze pressure [(cmH2O, mean?SD), 5?12 vs. 15?15, P=0.04] and mean change (delta) in PGI-S score [(mean ? SD), -0.2?0.9 vs. -0.8?0.8, P=0.04]. Within-group analysis showed that UDI-6 and IIQ-7 scores improved significantly from baseline to six weeks in the treatment group but not in the control group [UDI-6 score (mean?SD) 45?21 vs. 29?21, P=0.02; 43?18 vs. 33?26, P=0.22] [IIQ-7 score (mean?SD) 50?30 vs. 30?21, P=0.01; 48?23 vs.40?28, P=0.36]. PGI-S scores only improved in the treatment group from baseline to six weeks after treatment [PGI-S score (mean?SD) 3.1?0.8 vs. 2.3?0.8, P=0.0001]. BI-score, on average, improved significantly in the treatment and control group as well [SD unit, mean, from -1.06 to -0.58, P=0.001; from -0.66 to -0.42, P=0.04]. Conclusions: Women with stress-predominant urinary incontinence receiving a specially formulated supplement in addition to daily PFMT for six weeks had significantly improved urinary symptoms (decrease in UDI-6 score and IIQ-7) and BI-score compared to their baseline.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
urinary incontinence
Pelvic floor
Creatine
Zinc
Leucine
Megjelenés:BMC Womens Health. - 23 : 1 (2023), p. 1-12. -
További szerzők:Pákozdy Krisztina (1991-) (szülész-nőgyógyász) Koroknai Erzsébet (1987-) (szülész-nőgyógyász) Erdődi Balázs (1984-) (szülész-nőgyógyász szakorvosjelölt) Krasznai Zoárd Tibor (1973-) (szülész-nőgyógyász, gyermeknőgyógyász) Kozma Bence (1982-) (szülész-nőgyógyász)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM084852
Első szerző:Takács Péter (szülész-nőgyógyász)
Cím:Novel zinc containing vaginal moisturizer gel (JUVIA) improves postmenopausal vulvovaginal symptoms / Takács Péter, Kozma Bence, Erdődi Balázs, Póka Róbert
Dátum:2018
ISSN:0937-3462
Megjegyzések:Introduction: Many postmenopausal women suffer from vaginal dryness. Although vaginal estrogen is highly effective in alleviating this symptom, more and more women are reluctant to use hormonal treatment. Previous cell culture experiments revealed that zinc supplementation increases elastin and collagen synthesis. In addition, animal experiments revealed a beneficial effect of vaginal zinc treatment on the composition of the vagina in oophorectomized rats (1). Objectives: To evaluate the effect of a novel zinc containing vaginal moisturizer gel (JUVIA) on postmenopausal women vulvovaginal symptoms. Materials and Methods: Twenty postmenopausal women with genitourinary symptoms of menopause were enrolled. Patient were asked to use the JUVIA gel daily for 2 weeks. The novel gel was self-applied intra vaginally via a vaginal applicator. Two ml of gel was placed into the vagina nightly. Vaginal Health Index (Elasticity, Fluid Secretion, pH, Epithelial mucosa, Moisture) was calculated before and 1 week after the completion of treatment. Patients were asked to fill out a Visual Analog Scale (1-10, lower scores indicates less bother) on vaginal pain, dryness, burning, itching, dyspareunia and dysuria. Also validated questionnaire VSQ-21 was used to assess subjective symptoms of GSM before and one week after treatment. After completion of the treatment women were asked to complete an anonymous self-administered online 16 item questionnaire. Paired t-test was used to compare the before and after treatment results. Results: All patients were in menopause. The average age was 61?8 years. The Vaginal Health Index was 13?4 before and 19 ?4 after completion of treatment. VHI was significantly improved (P<0.01). The largest incremental change occurred in vaginal moisture out of the VHI. In sixty percent of women the vaginal pH remained normalized even a week after cessation of treatment. The patient reported VAS combined score was 17?17 before and 10?17 after treatment. VAS was significantly lower (P=0.04) after JUVIA treatment. VSQ-21 combined scores were 5?5 before and 2?4 after intervention. VSQ21 scores were significantly lower (P=0.01) indicative of symptom improvement. Seventy percent of sexually active women reported a significant improvement in the vulvar symptoms affecting sexual activity. Ninety percent of patients reported that during the treatment their vagina was well moisturized. Similarly 90% percent felt that the treatment was very comfortable. The moisturizing effect lasted for more than 1 week after cessation of treatment in 75% of women. Eighty-percent reported that the consistency of the product was adequate and 100% were satisfied with the smell of the gel. Seventy-five percent of participant felt more self-confident after using the gel and reported a significant improvement in the quality of sexual relationship. Overall ninety-percent of women were extremely satisfied or satisfied with the JUVIA treatment. Side effects were rare and minor. Conclusion: Novel zinc containing vaginal moisturizer gel (JUVIA) significantly improves postmenopausal vulvovaginal symptoms. Postmenopausal women were highly satisfied with the novel zinc containing vaginal moisturizer gel without serious side effects.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idézhető absztrakt
folyóiratcikk
Megjelenés:International Urogynecology Journal. - 29 : S1 (2018), p. 175. -
További szerzők:Kozma Bence (1982-) (szülész-nőgyógyász) Erdődi Balázs (1984-) (szülész-nőgyógyász szakorvosjelölt) Póka Róbert (1960-) (szülész-nőgyógyász, klinikai onkológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM078517
Első szerző:Takács Péter
Cím:Zinc-containing Vaginal Moisturizer Gel Improves Postmenopausal Vulvovaginal Symptoms : a Pilot Study / Peter Takacs, Bence Kozma, Balazs Erdodi, Attila Jakab, Kindra Larson, Robert Poka
Dátum:2019
ISSN:2288-6478 2288-6761
Megjegyzések:Objectives: Although vaginal estrogen is highly effective in alleviating genitourinary symptoms of menopause (GSM), some women are reluctant to use hormonal treatment. Our aim was to evaluate the effect of a zinc-containing vaginal moisturizer gel on GSM. Methods: Women with GSM were enrolled. Patients were asked to use the vaginal gel daily for 2 weeks. Vaginal Health Index (VHI) was calculated. Visual analogue scale (VAS) was obtained on vaginal pain, dryness, burning, itching, dyspareunia and dysuria before and 2 weeks after the completion of treatment. Vaginal cytology was obtained. Vulvovaginal symptom questionnaire (VSQ-21) was used to assess subjective symptoms. Results: Thirty-seven women with GSM participated in the study. The VHI improved significantly (mean ? standard deviation, 13 ? 4 before vs. 17 ? 4 after treatment, P < 0.01). The patient reported VAS combined score was significantly lower after the treatment (18 ? 14 before vs. 7 ? 12 after treatment, P < 0.01). The largest improvement occurred in vaginal dryness. The maturation value did not change significantly. There were no signs of inflammation on vaginal cytology. VSQ-21 combined scores also improved significantly (7.9 ? 5.5 before vs. 2.7 ? 3.6 after the intervention, P < 0.01). Side effects were rare and minor. Conclusions: Novel zinc-containing vaginal moisturizer gel significantly improves postmenopausal vulvovaginal symptoms without serious side effects.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Zinc
Vagina
Menopause
Megjelenés:Journal of Menopausal Medicine. - 25 : 1 (2019), p. 63-68. -
További szerzők:Kozma Bence (1982-) (szülész-nőgyógyász) Erdődi Balázs (1984-) (szülész-nőgyógyász szakorvosjelölt) Jakab Attila (1964-) (szülész-nőgyógyász, endokrinológus) Larson, Kindra Póka Róbert (1960-) (szülész-nőgyógyász, klinikai onkológus)
Pályázati támogatás:GINOP-2.1.1-15-2016-00783
GINOP
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1